JPRN-UMIN000002416已完成3 期
Efficacy of intra-hepatic arterial chemotherapy (IHAC) vs. sorafenib on advanced hepatocellular carcinoma; a prospective cohort study (ISHCC-cohort) - Intra-hepatic arterial chemotherapy (IHAC) vs. sorafenib for advanced hepatocellular carcinoma; a prospective cohort study (ISHCC-cohort)
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) histrogically confirmed combined type hepatocellular carcinoma or sarcomatous change 2) previous therapy for hepatocellular carcinoma within 30 days 3) inadequate for administration of sorafenib, 5-FU, cisplatin or interferon 4) active double cancer 5) severe complication 6) refractory ascites of pleural effusion 7) inappropriate for entry onto this study in the judgment of the investigator
研究者
相似试验
招募中
不适用
The efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced intrahepatic cholangiocarcinomaadvanced intrahepatic cholangiocarcinomaJPRN-UMIN000007303Iwate Medical University50
已完成
3 期
A Phase III Study of Intra-Arterial Hepatic Chemotherapy with 5-FU (WHF) in Patients with Liver Metastases from Colorectal Carcinomaiver excisionliver metastasis cancer of colorectal cancer originJPRN-C000000075Japanese Foundation for Multidisciplinary Treatment of Cancer280
已完成
不适用
Hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma: Prospective randomized studyAdvanced hepatocellular carcinomaJPRN-UMIN000005731First Department of Internal Medicine, Yamaguchi University School of Medicine30
招募中
不适用
Efficacy and safety of intra-arterial chemotherapy conccurent with radiotherapy for oral cancerOral cancerJPRN-UMIN000017747Department of Radiology Mie University Graduate School of Medicine35
招募中
不适用
HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLCBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatic Arterial Infusion ChemotherapyLenvatinibPD-1Systemic TherapyNCT06632093First Hospital of China Medical University84